Amy S Ruppert

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Genome Wide Association Study

Radiation Therapy

Chronic Lymphocytic Leukemia

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Audrey M Sigmund, Ying Huang, Amy S Ruppert, Kami Maddocks, Kerry A Rogers, Samantha M Jaglowski, Seema A Bhat, Adam S Kittai, Michael R Grever, John C Byrd, Jennifer A Woyach
Depth of response and progression-free survival in chronic lymphocytic leukemia patients treated with ibrutinib. Leukemia 36 (8) (2022)
Ann Steward LaCasce, Travis Dockter, Amy S Ruppert, Lale Kostakoglu, Heiko Schöder, Eric D Hsi, Jeffrey A Bogart, Bruce D Cheson, Nina Wagner-Johnston, Jeremy S Abramson, Kristie A Blum, John P Leonard, Nancy L Bartlett
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Janek S Walker, Zachary A Hing, Steven Sher, James Cronin, Katie Williams, Bonnie Harrington, Jordan N Skinner, Casey B Cempre, Charles T Gregory, Alexander Pan, Max Yano, Larry P Beaver, Brandi R Walker, Jadwiga M Labanowska, Nyla A Heerema, Krzysztof Mrózek, Jennifer A Woyach, Amy S Ruppert, Amy Lehman, Hatice Gulcin Ozer, Vincenzo Coppola, Pearlly S Yan, John C Byrd, James S Blachly, Rosa Lapalombella
Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia. Nature communications 12 (1) (2021)
Amy S Ruppert, Allison M Booth, Wei Ding, Nancy L Bartlett, Danielle M Brander, Steven Coutre, Jennifer R Brown, Sreenivasa Nattam, Richard A Larson, Harry Erba, Mark R Litzow, Carolyn Owen, Charles S Kuzma, Jeremy S Abramson, Richard F Little, Scott E Smith, Richard M Stone, John C Byrd, Sumithra J Mandrekar, Jennifer A Woyach
Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202. Leukemia 35 (10) (2021)